We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MA:NYSEMastercard Incorporated Analysis

Data as of 2026-05-21 - not real-time

$498.04

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Mastercard is trading at $498, just above its 20‑day SMA (~$500) but well below the 200‑day SMA (~$544), signaling a bearish bias in the longer term. The 14‑day RSI sits at 48, indicating neutral momentum, while the MACD line remains negative though the histogram has turned positive, suggesting a tentative bullish crossover. Volume trends are decreasing, and the 30‑day volatility is elevated at roughly 24%, underscoring heightened short‑term price swings.
Fundamentally, the company posted $33.9 bn of revenue with 15.8% YoY growth and ultra‑high operating margins (≈61%). Cash flow remains strong, with $16.1 bn free cash flow and a modest dividend payout ratio of 18%, supporting dividend sustainability. However, the DCF‑derived fair value of $438 is well below the current market price, implying the stock is overvalued by a sizable margin despite a forward P/E of 22.
Recent market commentary highlights Mastercard as a top pick among fintech leaders, with multiple analyst houses maintaining a “strong‑buy” consensus and median price targets near $662, reflecting confidence in secular digital‑payment tailwinds. Yet the same coverage notes a recent modest downgrade by Raymond James and Truist, tempering enthusiasm. Balancing the bullish fundamentals and optimistic analyst outlook against the technical weakness and valuation premium suggests a cautious but optimistic stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price below 200‑day SMA indicating bearish bias
  • decreasing volume and elevated volatility
  • valuation premium over DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 15.8% revenue growth and high operating margins
  • strong free cash flow and sustainable dividend
  • analyst consensus strong‑buy with median target $662

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • secular shift to digital payments
  • robust cash generation supporting long‑term shareholder returns
  • positioned in low‑beta, defensive financial services segment

Key Metrics & Analysis

Financial Health

Revenue Growth15.80%
Profit Margin45.88%
P/E Ratio28.8
ROE232.08%
ROA25.03%
Debt/Equity282.06
P/B Ratio65.7
Op. Cash Flow$18.3B
Free Cash Flow$16.1B
Industry P/E16.7

Technical Analysis

TrendBearish
RSI47.9
Support$488.01
Resistance$534.21
MA 20$500.51
MA 50$501.90
MA 200$544.10
MACDBullish
VolumeDecreasing
Fear & Greed Index89.82

Valuation

Fair Value$438.65
Target Price$646.97
Upside/Downside29.90%
GradeOvervalued
TypeGrowth
Dividend Yield0.70%

Risk Assessment

Beta0.58
Volatility24.38%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.